REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 188 filers reported holding REGENXBIO INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $684,604 | -65.7% | 41,592 | -12.6% | 0.00% | -66.7% |
Q3 2021 | $1,996,000 | +89.4% | 47,605 | +75.4% | 0.01% | +50.0% |
Q2 2021 | $1,054,000 | +38.1% | 27,142 | +21.4% | 0.00% | 0.0% |
Q1 2021 | $763,000 | -2.4% | 22,366 | +29.7% | 0.00% | -33.3% |
Q4 2020 | $782,000 | -37.6% | 17,239 | -62.2% | 0.01% | -64.7% |
Q3 2020 | $1,254,000 | +40.9% | 45,581 | +88.7% | 0.02% | +21.4% |
Q2 2020 | $890,000 | +189.9% | 24,156 | +154.4% | 0.01% | +75.0% |
Q1 2020 | $307,000 | -82.6% | 9,496 | -77.9% | 0.01% | -20.0% |
Q4 2019 | $1,761,000 | +41.7% | 42,980 | +23.1% | 0.01% | -9.1% |
Q3 2019 | $1,243,000 | -64.2% | 34,925 | -42.3% | 0.01% | -70.3% |
Q1 2019 | $3,469,000 | +191.8% | 60,537 | +113.6% | 0.04% | +164.3% |
Q4 2018 | $1,189,000 | +146.2% | 28,345 | +321.5% | 0.01% | +133.3% |
Q2 2018 | $483,000 | -38.0% | 6,725 | -74.2% | 0.01% | -50.0% |
Q1 2018 | $779,000 | -33.9% | 26,109 | -26.3% | 0.01% | -42.9% |
Q4 2017 | $1,178,000 | +428.3% | 35,421 | +194.2% | 0.02% | +133.3% |
Q4 2016 | $223,000 | – | 12,038 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |